Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Paul J Goodnick

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Expert Opinion on Pharmacotherapy|December 14, 2006
Seligiline transdermal system in depressionPaul J Goodnick
Expert Opinion on Pharmacotherapy|December 14, 2006
Bipolar depression: a review of randomised clinical trialsPaul J Goodnick
Expert Opinion on Drug Safety|July 14, 2005
Higher than Physician's Desk Reference (US) doses on atypical antipsychoticsPaul J Goodnick
Expert Opinion on Pharmacotherapy|March 1, 2006
Anticonvulsants in the treatment of bipolar maniaPaul J Goodnick
Expert Opinion on Pharmacotherapy|December 11, 2002
Aripiprazole: profile on efficacy and safetyPaul J Goodnick, Jason M Jerry
Expert Opinion on Pharmacotherapy|October 22, 2002
Antipsychotics: impact on prolactin levelsPaul J Goodnick, Lucero Rodriguez, Orlando Santana
Expert Opinion on Pharmacotherapy|May 9, 2002
Psychotropic drugs and the ECG: focus on the QTc intervalPaul J Goodnick, Jason Jerry, Francisco Parra
The Journal of Clinical Psychiatry|August 25, 2004
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg, Richard C Shelton, Paul Crits-Christoph, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Expert Opinion on Pharmacotherapy|December 14, 2006
Seligiline transdermal system in depressionPaul J Goodnick
Expert Opinion on Pharmacotherapy|December 14, 2006
Bipolar depression: a review of randomised clinical trialsPaul J Goodnick
Expert Opinion on Drug Safety|July 14, 2005
Higher than Physician's Desk Reference (US) doses on atypical antipsychoticsPaul J Goodnick
Expert Opinion on Pharmacotherapy|March 1, 2006
Anticonvulsants in the treatment of bipolar maniaPaul J Goodnick
Expert Opinion on Pharmacotherapy|December 11, 2002
Aripiprazole: profile on efficacy and safetyPaul J Goodnick, Jason M Jerry
Expert Opinion on Pharmacotherapy|October 22, 2002
Antipsychotics: impact on prolactin levelsPaul J Goodnick, Lucero Rodriguez, Orlando Santana
Expert Opinion on Pharmacotherapy|May 9, 2002
Psychotropic drugs and the ECG: focus on the QTc intervalPaul J Goodnick, Jason Jerry, Francisco Parra
The Journal of Clinical Psychiatry|August 25, 2004
The effectiveness of St. John's Wort in major depressive disorder: a naturalistic phase 2 follow-up in which nonresponders were provided alternate medicationAlan J Gelenberg, Richard C Shelton, Paul Crits-Christoph, et al.
Pageof 1